Related Experiment Videos
NSAI activity study of 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidine derivatives
V Darias1, S S Abdallah, M L Tello
1Departamento de Farmacología, Facultad de Farmacia, Universidad de La Laguna, Tenerife, Spain.
Archiv Der Pharmazie
|December 1, 1994
Summary
New anti-inflammatory drug candidates, 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidine derivatives, show significant pain relief without central nervous system effects. These compounds also exhibit low toxicity and minimal gastrointestinal issues.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Novel heterocyclic compounds are continuously explored for therapeutic potential.
- Benzo[4,5]thieno[2,3-d]pyrimidine scaffolds are of interest for developing new pharmaceuticals.
Purpose of the Study:
- To extensively investigate the pharmacological profile of 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidine derivatives.
- To evaluate the efficacy and safety of these compounds as potential anti-inflammatory and analgesic agents.
Main Methods:
- Synthesis and characterization of 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidine derivatives.
- In vivo pharmacological testing in established models of pain and inflammation.
- Assessment of central nervous system (CNS) activity, toxicity, and gastrointestinal effects.
Main Results:
- The studied compounds demonstrated significant analgesic activity, independent of central mechanisms.
- Effective anti-inflammatory properties were observed across various experimental inflammation models.
- Minimal to no central nervous system activity, low toxicity, and low gastrointestinal aggressivity were noted.
Conclusions:
- 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidine derivatives represent a promising class of compounds for managing pain and inflammation.
- Their favorable safety profile, including low toxicity and gastrointestinal impact, warrants further development.